← Eichor
Study identifier: NCT06306833 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

The Surface EMG Biofeedback as an Alternative Therapy to Reduce Chronic Low Back Pain

Condition: Chronic Low Back Pain  ·  Sponsor: Amaila Fazal [afazal]

PhaseNA
Planned participants200
Who can joinAll sexes, 25 Years to 75 Years
Healthy volunteersNo

About this study

The prevalence of chronic low back pain (CLBP) among the Pakistani population is reported to be as high as 78% leading towards different physiological and psychosocial alterations with the worst cases suffering from disabilities. CLBP is a multifactorial phenomenon in which age, gender, comorbidities, lifestyle conditions, profession, working hours, and different stressors play their roles in its causation. However, different therapeutic techniques have been determined to reduce CLBP. Thus, this study aimed to assess the effectiveness of the biofeedback surface EMG (sEMG) technique in reducing chronic low back pain among sufferers in the long run.

This description comes directly from the study's public registry record.

Talk to the study team

Amaila Fazal  ·  +923102686516  ·  amaila.fazal@gmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

Psychophysiology Lab, University of KarachiKarachi, Sindh, PakistanRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06306833